This October, Ennov will once again welcome customers from across Europe for our annual Europe User Meeting—a free event designed to foster collaboration, transparency, and
Are you still using spreadsheets, shared drives, or Word documents to manage your Trial Master File? Struggling to maintain compliance, oversight, or alignment with your
The era of stitching together disconnected e-clinical tools is ending, and the transformation is accelerating faster than expected. Clinical trials face unprecedented complexity. Decentralized models
The global clinical research landscape is undergoing a transformative shift with the adoption of ICH E6(R3)—the much-anticipated revision of the International Council for Harmonization’s (ICH)
The EMA’s eCTD 4.0 pilot is entering its next stage, and Ennov is ready to support Marketing Authorization Holders (MAHs) who are participating. Following our
The Challenge Japan’s move to eCTD 4.0 has created more questions than answers for pharmaceutical companies. For one of the world’s premier pharmaceutical companies, the
Clinical trial technology is supposed to streamline operations, not slow them down. But too often, the stack becomes the source of delay. This checklist outlines
Recognized by
